Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
What drives stock market index performance includes macro trends, earnings, and valuation shifts. This overview explains the main forces behind movements.
27,569 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A surprise board appointment paired with a sizable stock purchase has investors buzzing. Learn what this insider move...
SpaceX hits the public markets with a high-profile IPO, but the spacex president warning investors message underscore...
Marvell Technology’s stock rises to a 25-year high, lifting its S&P 500 position to No. 22. Analysts point to AI-driv...
Brookfield Corporation just bought back a substantial amount of its own stock. The move raises questions about whethe...
Alphabet raising $84.75 billion marks a bold turn in how tech giants fund AI bets. This article breaks down what it c...
delek holdings rallied today captured market attention as a mid-cap refiner with jet-fuel exposure and a strategic st...
Aehr Test Systems faces a pivotal Q4 print after the market closes, with AI burn-in demand and bookings in focus as t...
IBM’s dramatic one-day plunge coincided with blockbuster bank profits, fueling a debate over whether markets are misp...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Volatility is shaping a smarter approach to investing. Discover three growth stocks worth $5,000 and how to build a f...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...